-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on CVS Health, Raises Price Target to $93

Benzinga·12/10/2025 15:44:46
Listen to the news
Barclays analyst Andrew Mok maintains CVS Health (NYSE:CVS) with a Overweight and raises the price target from $87 to $93.